InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the full record of transactions filed by Fox Christine. Director active across 1 company, notably Teva Pharmaceutical Industries Ltd. Aggregated, 6 filings have been recorded. Split: 0 buy · 1 sell. Total volume traded: €648k. History available since 14 November 2025. The latest transaction was disclosed on 14 November 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Christine Fox is a declarant linked to Teva Pharmaceutical Industries Ltd, where she is EVP, U.S. Commercial. She has 6 filings in total, and across the 6 sampled filings the period runs from 2024-11-21 to 2026-03-09, with EUR 0 of buys and EUR 647630 of sells; the modal transaction nature is Levée d'options.